Organization Overview
Historical Acquisition Tree
Alternative names
Key: Celgene (9) Acquired (1)
fedratinib (Inrebic) (2019 NDA)
lenalidomide (revlimid) (2005 NDA)
luspatercept (Reblozyl) (2019 NDA)
thalidomide (Thalomid) (1998 NDA)
Key: Celgene (3) Acquired (2)
Key: Celgene (53) Acquired (5)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (2 trials)
acetylsalicylic acid (aspirin) (5 trials)
allogeneic stem cells (2 trials)
autologous mononuclear stem cell (6 trials)
bendamustine (treanda) (15 trials)
bortezomib (velcade) (29 trials)
carfilzomib (kyprolis) (16 trials)
clarithromycin (biaxin) (7 trials)
cyclophosphamide (cytoxan) (49 trials)
cytarabine (cytosar-u) (13 trials)
dacarbazine (dtic-dome) (2 trials)
daratumumab (darzalex) (13 trials)
docetaxel (taxotere) (6 trials)
doxorubicin (Doxil) (26 trials)
enasidenib (idhifa) (20 trials)
endostatin (endostar) (1 trial)
fedratinib (Inrebic) (8 trials)
gemcitabine (gemzar) (57 trials)
inactivated influenza vaccine (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
interferon beta-1b (betaseron) (1 trial)
ixazomib (ninlaro) (11 trials)
lenalidomide (revlimid) (325 trials)
luspatercept (Reblozyl) (12 trials)
melphalan (alkeran) (20 trials)
Key: Celgene (106) Acquired (15)
abemaciclib (verzenio) (2 trials)
allogeneic lymphocytes (3 trials)
allogeneic myeloma vaccine (1 trial)
allogeneic natural killer cells (3 trials)
allopurinol (zyloprim) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)
atezolizumab (tecentriq) (1 trial)
bacille calmette-guerin (1 trial)
belinostat (beleodaq) (1 trial)
bevacizumab (avastin) (15 trials)
bicalutamide (casodex) (1 trial)
cobimetinib (cotellic) (1 trial)
cyclosporine (sandimmune) (2 trials)
dalteparin (fragmin) (1 trial)
darbepoetin alfa (aranesp) (1 trial)
daunorubicin (cerubidine) (3 trials)
dc/aml fusion vaccine (1 trial)
dexmethylphenidate (focalin) (1 trial)
durvalumab (imfinzi) (21 trials)
elotuzumab (empliciti) (6 trials)
eltrombopag (promacta) (1 trial)
enoxaparin (lovenox) (1 trial)
erdafitinib (Balversa) (1 trial)
erlotinib (tarceva) (2 trials)
estramustine (emcyt) (1 trial)
ferumoxytol (feraheme) (1 trial)
filgrastim (neupogen) (7 trials)
fludarabine (fludara) (17 trials)
fluorouracil (efudex) (11 trials)
fulvestrant (faslodex) (1 trial)
gemtuzumab ozogamicin (mylotarg) (1 trial)
human placenta-derived cells (4 trials)
idarubicin (idamycin) (2 trials)
idelalisib (zydelig) (3 trials)
indomethacin (indocin) (1 trial)
ipilimumab (yervoy) (3 trials)
irinotecan (Camptosar) (5 trials)
Isatuximab (Sarclisa) (1 trial)
lisocabtagene maraleucel (3 trials)
methylprednisolone (medrol) (4 trials)
midostaurin (rydapt) (1 trial)
mitoxantrone (novantrone) (2 trials)
necitumumab (portrazza) (1 trial)
nelfinavir (viracept) (1 trial)
nivolumab (opdivo) (12 trials)
obinutuzumab (gazyva) (9 trials)
ofatumumab (arzerra) (5 trials)
palifermin (kepivance) (1 trial)
panitumumab (vectibix) (1 trial)
panobinostat (farydak) (2 trials)
peripheral blood hematopoietic cell (1 trial)
pertuzumab (perjeta) (2 trials)
pioglitazone (actos) (2 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)
pralatrexate (folotyn) (1 trial)
ramucirumab (cyramza) (2 trials)
ruxolitinib (jakafi) (2 trials)
sirolimus (rapamune) (2 trials)
sorafenib (nexavar) (6 trials)
tacrolimus (prograf) (2 trials)
tinzaparin (Innohep) (2 trials)
tocilizumab (actemra) (1 trial)
trastuzumab (herceptin) (7 trials)
trastuzumab emtansine (kadcyla) (1 trial)
tretinoin (Retin-A) (6 trials)
valproic acid (depakene) (4 trials)
venetoclax (venclexta) (6 trials)
Key: Celgene (80) Acquired (10)
4h11-28z/fil-12/efgrt+ genetically-modified t cells (1 trial)
abiraterone (zytiga) (1 trial)
aldesleukin (proleukin) (3 trials)
allogeneic cord blood (1 trial)
arsenic trioxide (trisenox) (1 trial)
autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 (1 trial)
brentuximab vedotin (adcetris) (1 trial)
ciltacabtagene autoleucel (Carvykti) (1 trial)
clofarabine (clolar) (1 trial)
decitabine (dacogen) (1 trial)
dextromethorphan (delsym) (1 trial)
diphenhydramine (benadryl) (1 trial)
egfrt/19-28z/4-1bbl car t cells (2 trials)
enzalutamide (xtandi) (1 trial)
fluvoxamine (luvox) (2 trials)
hla-mismatched stem cell (1 trial)
incomplete freund's adjuvant (1 trial)
itraconazole (sporanox) (4 trials)
ketoconazole (nizoral) (3 trials)
krn7000 loaded dendritic cells (1 trial)
metformin (glucophage) (3 trials)
moxifloxacin (avelox) (1 trial)
mycophenolate (myfortic) (1 trial)
omeprazole (prilosec) (4 trials)
palbociclib (ibrance) (2 trials)
phenelzine (nardil) (2 trials)
pseudoephedrine (Benylin) (1 trial)
rabeprazole (pariet) (1 trial)
rasagiline (azilect) (1 trial)
rosuvastatin (crestor) (4 trials)
sulfasalazine (azulfidine) (1 trial)
svn53-67/m57-klh peptide vaccine (1 trial)
temsirolimus (torisel) (2 trials)
trametinib (mekinist) (1 trial)
Acne Conglobata (Phase 2)
Acne Vulgaris (Phase 2)
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Disease (Phase 1)
Adenocarcinoma (Phase 4)
Adenocarcinoma, Follicular (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Agammaglobulinemia (Phase 2)
Aggression (Phase 2)
Alopecia (Phase 4)
Alopecia Areata (Phase 4)
Amyloidosis (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Anemia (Phase 3)
Anemia, Sickle Cell (Phase 1)
Angina Pectoris (Phase 2)
Arachnoiditis (Phase 2)
Arthritis (Phase 4)
Arthritis, Gouty (Phase 2)
Arthritis, Psoriatic (Phase 4)
Arthritis, Rheumatoid (Phase 2)
Astrocytoma (Phase 1)
Autoimmune Diseases (Phase 2)
Behcet Syndrome (Phase 3)
beta-Thalassemia (Phase 3)
Biliary Tract Neoplasms (Phase 2)
Blast Crisis (Phase 2)
Blood Protein Disorders (Phase 3)
Bone Marrow Diseases (Phase 1)
Brain Diseases (Phase 2)
Brain Ischemia (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Burkitt Lymphoma (Phase 2)
Cachexia (Phase 2)
Cancer Pain (Phase 2)
Carcinoma (Phase 4)
Carcinoma, Adenoid Cystic (Phase 1)
Carcinoma, Adenosquamous (Phase 2)
Carcinoma, Ductal (Phase 2)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Large Cell (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Pancreatic Ductal (Phase 1)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cardiovascular Diseases (Phase 4)
Central Nervous System Neoplasms (Phase 2)
Cholangiocarcinoma (Phase 2)
Cholangitis (Phase 2)
Cholangitis, Sclerosing (Phase 2)
Cholestasis (Phase 1)
Chondrosarcoma (Phase 2)
Chromosome Aberrations (Phase 2)
Chromosome Disorders (Phase 2)
Chronic Disease (Phase 2)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Complex Regional Pain Syndromes (Phase 2)
Congenital Abnormalities (Phase 3)
Coronary Artery Disease (Phase 2)
Coronary Restenosis (Phase 2)
Crohn Disease (Phase 3)
Dermatitis (Phase 4)
Dermatitis, Allergic Contact (Phase 2)
Dermatitis, Atopic (Phase 2)
Dermatitis, Contact (Phase 2)
Dermatofibrosarcoma (Phase 2)
Diabetic Foot (Phase 2)
Diabetic Nephropathies (Phase 2)
Diarrhea (Phase 2)
Digestive System Diseases (Phase 3)
Digestive System Neoplasms (Phase 3)
Disease (Phase 2)
Eczema (Phase 2)
Endocrine Gland Neoplasms (Phase 3)
Endocrine System Diseases (Phase 3)
Endometriosis (Phase 1)
Enteropathy-Associated T-Cell Lymphoma (Phase 1)
Eosinophilic Esophagitis (Phase 2)
Erdheim-Chester Disease (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophagitis (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fatigue (Phase 2)
Fatty Liver (Phase 2)
Fibrosarcoma (Phase 2)
Fibrosis (Phase 2)
Foot Ulcer (Phase 2)
Frailty (Phase 3)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Diseases (Phase 3)
Gastrointestinal Hemorrhage (Phase 3)
Gastrointestinal Neoplasms (Phase 3)
Genital Diseases, Female (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Graft vs Host Disease (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hematologic Diseases (Phase 3)
Hematologic Neoplasms (Phase 2)
Hemorrhage (Phase 3)
Hidradenitis (Phase 2)
Hidradenitis Suppurativa (Phase 2)
Histiocytic Sarcoma (Phase 2)
Histiocytoma (Phase 2)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
HIV Infections (Phase 2)
HIV Wasting Syndrome (Phase 2)
Hodgkin Disease (Phase 2)
Hyperbilirubinemia (Phase 1)
Hypersensitivity (Phase 2)
Hypertension (Phase 3)
Hypertension, Portal (Phase 3)
Hypoxia (Phase 2)
Hypoxia-Ischemia, Brain (Phase 2)
Idiopathic Interstitial Pneumonias (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Immune System Diseases (Phase 2)
Immunoblastic Lymphadenopathy (Phase 3)
Immunoglobulin G4-Related Disease (Phase 1)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Immunoproliferative Disorders (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Infarction, Posterior Cerebral Artery (Phase 2)
Infections (Phase 2)
Inflammation (Phase 4)
Inflammatory Breast Neoplasms (Phase 3)
Intestinal Diseases (Phase 1)
Intraocular Lymphoma (Phase 1)
Ischemia (Phase 2)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 1)
Leukemia, Biphenotypic, Acute (Phase 1)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Accelerated Phase (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 1)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Leukemia, T-Cell (Phase 2)
Lichen Planus (Phase 2)
Lichen Planus, Oral (Phase 2)
Lip Neoplasms (Phase 2)
Liposarcoma (Phase 1)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 2)
Lung Diseases (Phase 2)
Lung Diseases, Interstitial (Phase 2)
Lung Neoplasms (Phase 4)
Lupus Erythematosus, Cutaneous (Phase 2)
Lupus Erythematosus, Discoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lymphadenopathy (Phase 2)
Lymphatic Diseases (Phase 2)
Lymphocytosis (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Medulloblastoma (Phase 2)
Melanoma (Phase 3)
Mesothelioma (Phase 1)
Metaplasia (Phase 2)
Motor Neuron Disease (Phase 2)
Mouth Neoplasms (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 3)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms by Histologic Type (Phase 2)
Neoplasms by Site (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Nervous System Diseases (Phase 2)
Nervous System Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Neuroendocrine Tumors (Phase 2)
Neutropenia (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 2)
Oropharyngeal Neoplasms (Phase 2)
Osteoarthritis (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Diseases (Phase 3)
Pancreatic Neoplasms (Phase 3)
Pancreatitis (Phase 2)
Pancreatitis, Chronic (Phase 2)
Paraproteinemias (Phase 3)
Parapsoriasis (Phase 4)
Pathologic Processes (Phase 2)
Pelvic Pain (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Peritoneal Neoplasms (Phase 1)
Plasmacytoma (Phase 3)
POEMS Syndrome (Phase 2)
Polycythemia (Phase 3)
Polycythemia Vera (Phase 3)
Preleukemia (Phase 4)
Primary Myelofibrosis (Phase 3)
Prostatic Neoplasms (Phase 3)
Prostatitis (Phase 2)
Prurigo (Phase 2)
Pruritus (Phase 2)
Psoriasis (Phase 4)
Pulmonary Fibrosis (Phase 2)
Radiculopathy (Phase 3)
Recurrence (Phase 3)
Reflex Sympathetic Dystrophy (Phase 2)
Renal Insufficiency (Phase 2)
Respiratory Tract Diseases (Phase 2)
Retroperitoneal Fibrosis (Phase 1)
Rhabdomyosarcoma (Phase 2)
Rosacea (Phase 2)
Sarcoidosis (Phase 3)
Sarcoidosis, Pulmonary (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Localized (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 3)
Sezary Syndrome (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Smoldering Multiple Myeloma (Phase 2)
Somatoform Disorders (Phase 2)
Spinal Cord Compression (Phase 2)
Spondylarthritis (Phase 3)
Spondylitis (Phase 3)
Spondylitis, Ankylosing (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Stomatitis (Phase 1)
Stomatitis, Aphthous (Phase 1)
Stroke (Phase 2)
Syndrome (Phase 4)
Thalassemia (Phase 3)
Thrombocythemia, Essential (Phase 3)
Thrombocytopenia (Phase 3)
Thrombocytosis (Phase 3)
Thromboembolism (Phase 3)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Tuberculosis (Phase 2)
Tuberculosis, Pulmonary (Phase 2)
Tumor Virus Infections (Phase 1)
Ulcer (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uveitis (Phase 4)
Vascular Diseases (Phase 2)
Venous Thromboembolism (Phase 3)
Vitiligo (Phase 2)
Vulvodynia (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Wasting Syndrome (Phase 2)
Weight Loss (Phase 2)
Xeroderma Pigmentosum (Phase 2)